Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
160.3 USD | -1.36% | -0.79% | +3.54% |
04:08pm | Daiwa Securities Adjusts Price Target on AbbVie to $171 From $190 | MT |
09:57am | Medincell: listing suspended pending a press release | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.54% | 287B | |
+32.91% | 700B | |
-4.94% | 358B | |
+19.18% | 330B | |
+16.23% | 236B | |
+6.67% | 202B | |
-9.20% | 197B | |
+5.56% | 161B | |
-2.73% | 157B | |
+3.77% | 124B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Genmab, AbbVie Secure US FDA's Priority Review Tag for Blood Cancer Therapy